InsiderClue
← All stocks

Syndax Pharmaceuticals Inc

SNDX Mostly scheduled
CIK 0001395937 #2145 in the set updated 17 Sep 2026
Bought (120 mo)
$789.78K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$54.61M
$0.00 on a plan · $53.35M straight out of an exercise
Sold at will
$1.25M
15 of 114 sales
Net
−$53.82M
−$463.51K against sales at will

By person

19 insiders · 130 transactions
15.5×

Michael A. Metzger holds 15.5 times base salary in stock. $11.75M of shares against $754.30K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael A. Metzger last reported holding, valued at $24.24, the price Common Stock was last bought or sold at on the open market here, on 8 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Morrison Briggs
Director
$311.64K (4)
$26.01M (25) scheduled
−$25.70M
34,836
0.0390%
$844.43K
+1,207%
Metzger Michael A
Chief Executive Officer
—
$15.40M (34) scheduled
−$15.40M
484,843
0.5430%
$11.75M
—
Ordentlich Peter
Chief Scientific Officer
—
$2.81M (14) scheduled
−$2.81M
0
0.0000%
$0.00
−100.0%
Podlesak Dennis
Director
$197.08K (1)
$2.77M (6) scheduled
−$2.58M
239,763
0.2685%
$5.81M
—
Legault Pierre
Director
—
$2.55M (7) scheduled
−$2.55M
114,000
0.1277%
$2.76M
—
Meury William
Director
—
$1.70M (3) scheduled
−$1.70M
90,000
0.1008%
$2.18M
—
Botwood Nicholas A.J.
Head of R&D, CMO
$105.83K (1)
$1.18M (2) scheduled
−$1.08M
60,885
0.0682%
$1.48M
+6,780%
Egros Fabrice
Director
—
$1.00M (7) scheduled
−$1.00M
32,000
0.0358%
$775.69K
—
Katkin Keith
Director
$91.12K (1)
$877.19K (8) scheduled
−$786.07K
124,000
0.1389%
$3.01M
—
Goldan Keith A.
Chief Financial Officer
$25.04K (2)
$220.45K (6)
−$195.42K
139,252
0.1559%
$3.38M
—
Gallagher Neil
President, Head of R&D
—
$71.60K (1)
−$71.60K
85,095
0.0953%
$2.06M
—
Huber Martin H. Jr.
Director
$44.95K (1)
—
+$44.95K
103,000
0.1153%
$2.50M
—
Nolte Alexander
Chief Accounting Officer
—
$16.12K (1)
−$16.12K
0
0.0000%
$0.00
—
Meyers Michael L.
SVP, Chief Medical Officer
$14.12K (4)
—
+$14.12K
23,280
0.0261%
$564.31K
+955.3%
ROYSTON IVOR
Director
—
—
—
625,545
0.7005%
$15.16M
−16.7%
Jarrett Jennifer
Director
—
—
—
114,000
0.1277%
$2.76M
—
BVF PARTNERS L P/IL entity
10% owner
—
—
—
85,038
0.0952%
$2.06M
−95.9%
Rizo Aleksandra
Director
—
—
—
49,000
0.0549%
$1.19M
—
Shea Richard P
Chief Financial Officer
—
—
—
7,121
0.0080%
$172.61K
+320.4%

Individual transactions

130
Insider
Date
Role
Action
Shares
Price
Amount
Metzger Michael A
8 Jul 2026
Chief Executive Officer
Sold after exercise
32,375
$24.24
$784.78K
Botwood Nicholas A.J.
12 Jun 2026
Head of R&D, CMO
Sold after exercise
31,235
$18.14
$566.60K
Botwood Nicholas A.J.
11 Jun 2026
Head of R&D, CMO
Sold after exercise
34,280
$18.00
$617.04K
Metzger Michael A
1 Jun 2026
Chief Executive Officer
Sell
6,847
$18.99
$130.02K
Goldan Keith A.
1 Jun 2026
Chief Financial Officer
Sell
1,177
$18.99
$22.35K
Goldan Keith A.
9 Feb 2026
Chief Financial Officer
Sell
3,410
$21.03
$71.71K
Metzger Michael A
9 Feb 2026
Chief Executive Officer
Sell
17,159
$21.03
$360.82K
Goldan Keith A.
6 Feb 2026
Chief Financial Officer
Sell
2,082
$20.62
$42.93K
Metzger Michael A
6 Feb 2026
Chief Executive Officer
Sell
7,412
$20.62
$152.84K
Metzger Michael A
8 Sep 2025
Chief Executive Officer
Sold after exercise
157,307
$16.41
$2.58M
Podlesak Dennis
18 Aug 2025
Director
Sold after exercise
19,200
$15.84
$304.17K
Podlesak Dennis
15 Aug 2025
Director
Sold after exercise
19,200
$15.54
$298.41K
Podlesak Dennis
14 Aug 2025
Director
Sold after exercise
19,200
$14.19
$272.52K
Metzger Michael A
16 Jul 2025
Chief Executive Officer
Sell
7,534
$9.29
$69.95K
Goldan Keith A.
16 Jul 2025
Chief Financial Officer
Sell
1,296
$9.29
$12.03K
Katkin Keith
19 May 2025
Director
Buy
10,000
$9.11
$91.12K
Huber Martin H. Jr.
19 May 2025
Director
Buy
5,000
$8.99
$44.95K
Goldan Keith A.
19 May 2025
Chief Financial Officer
Buy
3,000
—
no price
Botwood Nicholas A.J.
16 May 2025
Head of R&D, CMO
Buy
11,765
$9.00
$105.83K
Metzger Michael A
14 Mar 2025
Chief Executive Officer
Exercised, kept
6,074
$7.20
$43.73K
Metzger Michael A
4 Mar 2025
Chief Executive Officer
Sold after exercise
7,814
$15.05
$117.56K
Gallagher Neil
10 Feb 2025
President, Head of R&D
Sell
4,618
$15.50
$71.60K
Metzger Michael A
10 Feb 2025
Chief Executive Officer
Sell
13,288
$15.50
$206.02K
Goldan Keith A.
10 Feb 2025
Chief Financial Officer
Sell
3,777
$15.50
$58.56K
Goldan Keith A.
14 Jun 2024
Chief Financial Officer
Buy
1,250
$20.03
$25.04K
Morrison Briggs
9 Aug 2023
Director
Sold after exercise
52,855
$18.27
$965.40K
Meury William
2 Aug 2023
Director
Sold after exercise
24,000
$20.45
$490.91K
Meury William
2 Aug 2023
Director
Sold after exercise
24,000
$20.46
$490.95K
Meury William
2 Aug 2023
Director
Sold after exercise
35,000
$20.46
$715.95K
Morrison Briggs
10 Jul 2023
Director
Sold after exercise
52,855
$20.40
$1.08M
Goldan Keith A.
13 Jun 2023
Chief Financial Officer
Sell
577
$22.31
$12.87K
Morrison Briggs
9 Jun 2023
Director
Sold after exercise
28,273
$21.18
$598.80K
Morrison Briggs
9 Jun 2023
Director
Sold after exercise
24,582
$21.18
$520.62K
Morrison Briggs
9 May 2023
Director
Sold after exercise
52,855
$21.41
$1.13M
Morrison Briggs
10 Apr 2023
Director
Sold after exercise
52,855
$19.53
$1.03M
Morrison Briggs
13 Mar 2023
President, Head of R&D
Sold after exercise
52,854
$22.53
$1.19M
Ordentlich Peter
15 Feb 2023
Chief Scientific Officer
Sold after exercise
17,428
$25.84
$450.40K
Ordentlich Peter
15 Feb 2023
Chief Scientific Officer
Sold after exercise
7,572
$25.84
$195.69K
Morrison Briggs
6 Feb 2023
President, Head of R&D
Sold after exercise
52,854
$26.83
$1.42M
Metzger Michael A
6 Feb 2023
Chief Executive Officer
Sold after exercise
5,959
$27.64
$164.70K
Ordentlich Peter
1 Feb 2023
Chief Scientific Officer
Sell
69
$28.43
$1.96K
Legault Pierre
13 Jan 2023
Director
Sold after exercise
5,000
$27.00
$135.00K
Legault Pierre
13 Jan 2023
Director
Sold after exercise
10,000
$27.00
$270.00K
Legault Pierre
12 Jan 2023
Director
Sold after exercise
24,000
$26.74
$641.78K
Ordentlich Peter
2 Dec 2022
Chief Scientific Officer
Sold after exercise
17,200
$25.05
$430.94K
Ordentlich Peter
1 Dec 2022
Chief Scientific Officer
Sold after exercise
4,028
$25.01
$100.75K
Ordentlich Peter
1 Dec 2022
Chief Scientific Officer
Sold after exercise
3,772
$25.01
$94.34K
Metzger Michael A
6 Oct 2022
Chief Executive Officer
Sold after exercise
16,231
$25.29
$410.51K
Katkin Keith
6 Oct 2022
Director
Sold after exercise
9,117
$25.90
$236.14K
Katkin Keith
6 Oct 2022
Director
Sold after exercise
20,782
$25.90
$538.27K
Katkin Keith
4 Oct 2022
Director
Sold after exercise
223
$25.00
$5.58K
Katkin Keith
4 Oct 2022
Director
Sold after exercise
137
$25.00
$3.43K
Metzger Michael A
4 Oct 2022
Chief Executive Officer
Sold after exercise
1,280
$25.02
$32.03K
Katkin Keith
3 Oct 2022
Director
Sold after exercise
13
$25.00
$325.00
Katkin Keith
3 Oct 2022
Director
Sold after exercise
167
$25.00
$4.18K
Metzger Michael A
3 Oct 2022
Chief Executive Officer
Sold after exercise
2,883
$25.01
$72.11K
Katkin Keith
30 Sep 2022
Director
Sold after exercise
647
$25.07
$16.22K
Katkin Keith
30 Sep 2022
Director
Sold after exercise
2,914
$25.07
$73.06K
Metzger Michael A
30 Sep 2022
Chief Executive Officer
Sold after exercise
29,606
$25.02
$740.76K
Morrison Briggs
20 Sep 2022
President, Head of R&D
Sold after exercise
59,649
$23.25
$1.39M
Morrison Briggs
19 Sep 2022
President, Head of R&D
Sold after exercise
114,339
$23.03
$2.63M
Podlesak Dennis
16 Sep 2022
Director
Sold after exercise
6,556
$23.43
$153.62K
Podlesak Dennis
16 Sep 2022
Director
Sold after exercise
5,419
$23.43
$126.98K
Morrison Briggs
16 Sep 2022
President, Head of R&D
Sold after exercise
53,034
$23.22
$1.23M
Morrison Briggs
16 Sep 2022
President, Head of R&D
Sold after exercise
71,966
$23.22
$1.67M
Podlesak Dennis
15 Sep 2022
Director
Sold after exercise
66,840
$24.20
$1.62M
Morrison Briggs
15 Sep 2022
President, Head of R&D
Sold after exercise
66,775
$24.20
$1.62M
Morrison Briggs
14 Sep 2022
President, Head of R&D
Sold after exercise
87,645
$23.80
$2.09M
Ordentlich Peter
24 Aug 2022
Chief Scientific Officer
Sold after exercise
2,154
$25.04
$53.93K
Ordentlich Peter
24 Aug 2022
Chief Scientific Officer
Sold after exercise
22,846
$25.04
$571.97K
Legault Pierre
5 Aug 2022
Director
Sold after exercise
14,000
$23.02
$322.22K
Legault Pierre
5 Aug 2022
Director
Sold after exercise
10,000
$23.02
$230.16K
Metzger Michael A
25 Jul 2022
Chief Executive Officer
Sold after exercise
11,838
$21.06
$249.25K
Metzger Michael A
25 Jul 2022
Chief Executive Officer
Sold after exercise
19,764
$21.06
$416.14K
Metzger Michael A
7 Jul 2022
Chief Executive Officer
Sold after exercise
100
$21.00
$2.10K
Metzger Michael A
6 Jul 2022
Chief Executive Officer
Sold after exercise
15,009
$21.07
$316.31K
Morrison Briggs
1 Jul 2022
President, Head of R&D
Sold after exercise
62,292
$19.00
$1.18M
Morrison Briggs
4 Apr 2022
President, Head of R&D
Sold after exercise
3,128
$18.29
$57.22K
Morrison Briggs
1 Apr 2022
President, Head of R&D
Sold after exercise
70,545
$17.46
$1.23M
Morrison Briggs
1 Apr 2022
President, Head of R&D
Sold after exercise
24,500
$17.44
$427.31K
Morrison Briggs
1 Apr 2022
President, Head of R&D
Sold after exercise
6,000
$17.44
$104.63K
Nolte Alexander
1 Feb 2022
Chief Accounting Officer
Sell
968
$16.65
$16.12K
Ordentlich Peter
1 Feb 2022
Chief Scientific Officer
Sell
1,412
$16.65
$23.51K
Meyers Michael L.
30 Dec 2021
SVP, Chief Medical Officer
Exercised, kept
5,900
$8.77
$51.74K
Legault Pierre
22 Dec 2021
Director
Sold after exercise
24,000
$22.01
$528.21K
Metzger Michael A
20 Dec 2021
President and COO
Sold after exercise
45,000
$20.29
$912.96K
Metzger Michael A
20 Dec 2021
President and COO
Sold after exercise
16,000
$20.29
$324.61K
Legault Pierre
20 Dec 2021
Director
Sold after exercise
20,000
$21.01
$420.25K
Metzger Michael A
17 Dec 2021
President and COO
Sold after exercise
1,676
$19.02
$31.88K
Morrison Briggs
17 Dec 2021
Chief Executive Officer
Sold after exercise
35,156
$20.00
$703.12K
Metzger Michael A
16 Dec 2021
President and COO
Sold after exercise
22,715
$19.08
$433.40K
Metzger Michael A
13 Dec 2021
President and COO
Sold after exercise
34,564
$19.05
$658.55K
Metzger Michael A
13 Dec 2021
President and COO
Sold after exercise
2,045
$19.05
$38.96K
Egros Fabrice
18 Nov 2021
Director
Sold after exercise
30
$18.03
$540.97
Egros Fabrice
18 Nov 2021
Director
Sold after exercise
14,000
$18.03
$252.45K
Metzger Michael A
26 Oct 2021
President and COO
Sold after exercise
16,296
$19.20
$312.82K
Metzger Michael A
25 Oct 2021
President and COO
Sold after exercise
44,704
$19.13
$855.34K
Metzger Michael A
27 Sep 2021
President and COO
Sold after exercise
24,437
$19.51
$476.83K
Metzger Michael A
22 Sep 2021
President and COO
Sold after exercise
300
$19.02
$5.71K
Metzger Michael A
21 Sep 2021
President and COO
Sold after exercise
4,808
$19.16
$92.11K
Morrison Briggs
20 Sep 2021
Chief Executive Officer
Sold after exercise
50
$20.00
$1.00K
Metzger Michael A
20 Sep 2021
President and COO
Sold after exercise
31,455
$19.24
$605.05K
Morrison Briggs
17 Sep 2021
Chief Executive Officer
Sold after exercise
70,262
$20.07
$1.41M
Metzger Michael A
14 Sep 2021
President and COO
Sold after exercise
44,349
$19.15
$849.39K
Metzger Michael A
13 Sep 2021
President and COO
Sold after exercise
16,651
$19.02
$316.64K
Egros Fabrice
18 Aug 2021
Director
Sold after exercise
15,635
$15.75
$246.33K
Egros Fabrice
18 May 2021
Director
Sold after exercise
1,683
$18.65
$31.38K
Egros Fabrice
18 May 2021
Director
Sold after exercise
11,926
$18.65
$222.40K
Meyers Michael L.
26 Apr 2021
SVP, Chief Medical Officer
Buy
500
$15.46
$7.73K
Podlesak Dennis
22 Apr 2021
Director
Buy
13,967
$14.11
$197.08K
Egros Fabrice
1 Mar 2021
Director
Sold after exercise
74
$24.31
$1.80K
Egros Fabrice
1 Mar 2021
Director
Sold after exercise
10,167
$24.31
$247.18K
Morrison Briggs
8 Feb 2021
Chief Executive Officer
Sold after exercise
35,156
$20.55
$722.40K
Metzger Michael A
1 Feb 2021
President and COO
Sold after exercise
15,000
$20.19
$302.80K
Metzger Michael A
1 Dec 2020
President and COO
Sold after exercise
15,000
$22.97
$344.51K
Ordentlich Peter
23 Nov 2020
Chief Scientific Officer
Sold after exercise
16,334
$22.89
$373.92K
Ordentlich Peter
23 Nov 2020
Chief Scientific Officer
Sold after exercise
7,954
$23.58
$187.59K
Ordentlich Peter
23 Nov 2020
Chief Scientific Officer
Sold after exercise
5,684
$23.33
$132.60K
Morrison Briggs
10 Nov 2020
Chief Executive Officer
Sold after exercise
17,466
$20.06
$350.31K
Morrison Briggs
9 Nov 2020
Chief Executive Officer
Sold after exercise
62,938
$20.04
$1.26M
Metzger Michael A
4 Nov 2020
President and COO
Sold after exercise
100,000
$20.31
$2.03M
Morrison Briggs
4 Feb 2020
Chief Executive Officer
Buy
12,500
$8.00
$100.00K
Morrison Briggs
10 Oct 2019
Chief Executive Officer
Buy
11,000
$5.40
$59.40K
Morrison Briggs
13 May 2019
Chief Executive Officer
Buy
7,200
$7.29
$52.52K
Morrison Briggs
9 May 2019
Chief Executive Officer
Buy
13,200
$7.56
$99.73K
Meyers Michael L.
21 Mar 2019
SVP, Chief Medical Officer
Buy
104
$4.87
$506.48
Meyers Michael L.
21 Mar 2019
SVP, Chief Medical Officer
Buy
1,000
$4.93
$4.93K
Meyers Michael L.
30 Oct 2018
SVP, Chief Medical Officer
Buy
200
$4.79
$958.00
Ordentlich Peter
3 Apr 2018
Chief Scientific Officer
Sold after exercise
7,500
$15.00
$112.50K
Ordentlich Peter
17 May 2017
Chief Scientific Officer
Sold after exercise
5,000
$15.00
$75.00K

What was left out

Form 4 filings counted 215
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 99
Sales at will 15
Transactions with no price 1
Shares from compensation/vesting 6,340,977
Sales filed before the plan box existed 3
History held since 2 Nov 2016